Citius Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTXR and other ETFs, options, and stocks.

About CTXR

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. 

CEO
Leonard L. Mazur
CEOLeonard L. Mazur
Employees
21
Employees21
Headquarters
Cranford, New Jersey
HeadquartersCranford, New Jersey
Founded
2007
Founded2007
Employees
21
Employees21

CTXR Key Statistics

Market cap
201.77M
Market cap201.77M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.96M
Average volume1.96M
High today
$1.39
High today$1.39
Low today
$1.35
Low today$1.35
Open price
$1.35
Open price$1.35
Volume
10.00K
Volume10.00K
52 Week high
$2.01
52 Week high$2.01
52 Week low
$0.77
52 Week low$0.77

CTXR Earnings

-$0.06
-$0.04
-$0.02
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
per share
Estimated per share
Actual
Expected Feb 9, After Hours
ActualExpected Feb 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.